0001662622-17-000001.txt : 20170728 0001662622-17-000001.hdr.sgml : 20170728 20170727175033 ACCESSION NUMBER: 0001662622-17-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170728 DATE AS OF CHANGE: 20170727 EFFECTIVENESS DATE: 20170728 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Rebound Therapeutics Corp CENTRAL INDEX KEY: 0001662622 IRS NUMBER: 475468800 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-291665 FILM NUMBER: 17987281 BUSINESS ADDRESS: STREET 1: 13844 ALTON PARKWAY, SUITE 131 CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: 949-581-7250 MAIL ADDRESS: STREET 1: 13844 ALTON PARKWAY, SUITE 131 CITY: IRVINE STATE: CA ZIP: 92618 D 1 primary_doc.xml X0708 D LIVE 0001662622 Rebound Therapeutics Corp 13844 ALTON PARKWAY, SUITE 131 IRVINE CA CALIFORNIA 92618 949-581-7250 DELAWARE None None Corporation true 2015 Jeffrey J. Valko 13844 ALTON PARKWAY, SUITE 131 IRVINE CA CALIFORNIA 92618 Executive Officer Director Michael R. Henson 13844 ALTON PARKWAY, SUITE 131 IRVINE CA CALIFORNIA 92618 Executive Officer Director Tracy Pearson 13844 ALTON PARKWAY, SUITE 131 IRVINE CA CALIFORNIA 92618 Executive Officer Other Technology Decline to Disclose 06b false 2017-07-14 false true false 5000 16499999 16499999 0 Series B Preferred Stock false 49 0 0 0 false Rebound Therapeutics Corp /s/: Jeffrey J. Valko Jeffrey J. Valko President & CEO 2017-07-26